疑似围术期速发型超敏反应共识临床评分
通过25名国际多学科专家两轮Delphi共识,从60条陈述中筛选43条制定疑似围术期速发型超敏反应临床评分系统,并纳入肥大细胞类胰蛋白酶补充评分;临床情景评分支持其有效性。
要点
- 该评分系统用于估计疑似围术期速发型超敏反应的可能性,非严重程度分级。
- 43条陈述经Delphi共识达到适当性与一致性标准,用于构建评分。
- 肥大细胞类胰蛋白酶变化解读存在专家间差异,但仍纳入补充评分。
核心结论
- 采用稳健的共识制定流程建立了疑似围术期速发型超敏反应的临床评分系统,可提高诊断试验敏感性评估的客观性与一致性。
研究设计与样本
- Delphi共识流程,由25名国际多学科围术期过敏领域专家参与,共两轮。
主要发现
- 初始60条陈述中43条被评为适当(中位评分≥7)且满足一致性标准(不一致指数<0.5)。
- 临床情景的评分结果支持该评分系统的有效性。
- 专家组对肥大细胞类胰蛋白酶变化的解读存在差异,但仍纳入了补充评分。
关键数值与推荐
- 适当性评分采用1-9分制,中位评分≥7视为适当。
- 一致性标准为不一致指数<0.5。
- 两轮Delphi流程对所有陈述达到停止标准。
临床怎么用
- 可用于围术期疑似速发型超敏反应的可能性评估,并辅助诊断试验的敏感性评价。
局限性
- 专家组对肥大细胞类胰蛋白酶变化的解读存在变异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Grading schemes for severity of suspected allergic reactions have been applied to the perioperative setting, but there is no scoring system that estimates the likelihood that the reaction is an immediate hypersensitivity reaction. Such a score would be useful in evaluating current and proposed tests for the diagnosis of suspected perioperative immediate hypersensitivity reactions and culprit agents. METHODS: We conducted a Delphi consensus process involving a panel of 25 international multidisciplinary experts in suspected perioperative allergy. Items were ranked according to appropriateness (on a scale of 1-9) and consensus, which informed development of a clinical scoring system. The scoring system was assessed by comparing scores generated for a series of clinical scenarios against ratings of panel members. Supplementary scores for mast cell tryptase were generated. RESULTS: Two rounds of the Delphi process achieved stopping criteria for all statements. From an initial 60 statements, 43 were rated appropriate (median score 7 or more) and met agreement criteria (disagreement index <0.5); these were used in the clinical scoring system. The rating of clinical scenarios supported the validity of the scoring system. Although there was variability in the interpretation of changes in mast cell tryptase by the panel, we were able to include supplementary scores for mast cell tryptase. CONCLUSION: We used a robust consensus development process to devise a clinical scoring system for suspected perioperative immediate hypersensitivity reactions. This will enable objectivity and uniformity in the assessment of the sensitivity of diagnostic tests.
引用
- Hopkins PM, Cooke PJ, Clarke RC, et al. Consensus clinical scoring for suspected perioperative immediate hypersensitivity reactions. Br J Anaesth. 2019. PMID: 31029409. doi:10.1016/j.bja.2019.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。